• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆N末端脑钠肽作为慢性重度二尖瓣反流患者功能状态标志物的效用

Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.

作者信息

Yusoff Rahal, Clayton Nigel, Keevil Brian, Morris Julie, Ray Simon

机构信息

Department of Cardiology, South Manchester University Hospitals, Wythenshawe, Manchester, United Kingdom.

出版信息

Am J Cardiol. 2006 May 15;97(10):1498-501. doi: 10.1016/j.amjcard.2005.11.085. Epub 2006 Mar 29.

DOI:10.1016/j.amjcard.2005.11.085
PMID:16679092
Abstract

Plasma levels of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) are elevated in severe mitral regurgitation, but their relation to functional capacity and cardiac remodeling is not well defined. We evaluated the role of NT-pro-BNP as a marker of functional capacity, symptoms, and cardiac remodeling in 38 patients with severe degenerative mitral regurgitation and preserved left ventricular ejection fraction. The NT-pro-BNP levels increased progressively with New York Heart Association (NYHA) functional class: NYHA class I (geometric mean [GM] 97.1 pg/ml), NYHA class II (GM 169.8 pg/ml), and NYHA III (GM 457.6 pg/ml; p = 0.015). The end-systolic volume index (r = 0.52, p = 0.001), end-diastolic volume index (r = 0.46, p = 0.003), left atrial volume index (r = 0.4, p = 0.01), regurgitant volume index (r = 0.38, p = 0.02), regurgitant fraction (r = 0.46, p = 0.003), and end-diastolic sphericity index (r = 0.56, p <0.001) all correlated significantly with NT-pro-BNP. The NT-pro-BNP levels correlated significantly with the exercise parameters: maximum oxygen uptake (r = -0.6, p <0.001), exercise time (r = -0.52, p <0.001), and oxygen pulse (r = -0.57, p <0.001). In contrast, only weak correlations were obtained between the exercise and echocardiographic variables. NT-pro-BNP was a strong independent predictor of maximum oxygen uptake (p = 0.001). In conclusion, the results of this study have demonstrated that NT-pro-BNP increases progressively with worsening symptoms, is linked to the extent of LV remodeling, and is an independent predictor of functional capacity. NT-pro-BNP may have a role in the optimal treatment of patients with severe mitral regurgitation.

摘要

严重二尖瓣反流患者的血浆N末端脑钠肽前体(NT-pro-BNP)水平升高,但其与心功能和心脏重塑的关系尚不明确。我们评估了NT-pro-BNP作为38例严重退行性二尖瓣反流且左心室射血分数保留患者的心功能、症状和心脏重塑标志物的作用。NT-pro-BNP水平随纽约心脏协会(NYHA)心功能分级逐渐升高:NYHA I级(几何均数[GM] 97.1 pg/ml)、NYHA II级(GM 169.8 pg/ml)和NYHA III级(GM 457.6 pg/ml;p = 0.015)。收缩末期容积指数(r = 0.52,p = 0.001)、舒张末期容积指数(r = 0.46,p = 0.003)、左心房容积指数(r = 0.4,p = 0.01)、反流容积指数(r = 0.38,p = 0.02)、反流分数(r = 0.46,p = 0.003)和舒张末期球形指数(r = 0.56,p <0.001)均与NT-pro-BNP显著相关。NT-pro-BNP水平与运动参数显著相关:最大摄氧量(r = -0.6,p <0.001)、运动时间(r = -0.52,p <0.001)和氧脉搏(r = -0.57,p <0.001)。相比之下,运动与超声心动图变量之间仅存在弱相关性。NT-pro-BNP是最大摄氧量的强有力独立预测因子(p = 0.001)。总之,本研究结果表明,NT-pro-BNP随症状恶化而逐渐升高,与左心室重塑程度相关,是心功能的独立预测因子。NT-pro-BNP可能在严重二尖瓣反流患者的优化治疗中发挥作用。

相似文献

1
Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.血浆N末端脑钠肽作为慢性重度二尖瓣反流患者功能状态标志物的效用
Am J Cardiol. 2006 May 15;97(10):1498-501. doi: 10.1016/j.amjcard.2005.11.085. Epub 2006 Mar 29.
2
Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.N末端前B型利钠肽与器质性二尖瓣反流患者症状、严重程度及左心室重构的关系。
Am J Cardiol. 2009 Aug 15;104(4):559-64. doi: 10.1016/j.amjcard.2009.04.023. Epub 2009 Jun 18.
3
Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in patients with mitral regurgitation.二尖瓣反流患者心肌性能指数与血浆B型利钠肽水平的相关性
Int J Cardiovasc Imaging. 2008 Feb;24(2):151-7. doi: 10.1007/s10554-007-9237-5. Epub 2007 May 31.
4
Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.N端前B型利钠肽水平对预测肥厚型心肌病运动能力的有用性。
Am J Cardiol. 2006 Aug 15;98(4):515-9. doi: 10.1016/j.amjcard.2006.02.057. Epub 2006 Jun 27.
5
N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.N末端前体脑钠肽作为检测低心功能分级患者和心脏移植候选者的标志物:与运动耐量的线性相关性。
J Heart Lung Transplant. 2007 May;26(5):516-21. doi: 10.1016/j.healun.2007.01.026. Epub 2007 Mar 21.
6
N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.N末端前脑钠肽与非对称性肥厚型心肌病患者的冠状动脉血流储备及舒张功能障碍相关。
J Cardiol. 2017 Oct;70(4):323-328. doi: 10.1016/j.jjcc.2017.02.008. Epub 2017 Mar 21.
7
Role of Right Ventricular Dysfunction and Diabetes Mellitus in N-terminal pro-B-type Natriuretic Peptide Response of Patients With Severe Mitral Regurgitation and Heart Failure After MitraClip.右心室功能障碍和糖尿病在重度二尖瓣反流患者经MitraClip治疗后发生心力衰竭时N末端B型利钠肽原反应中的作用
Int Heart J. 2017 Apr 6;58(2):225-231. doi: 10.1536/ihj.16-255. Epub 2017 Feb 20.
8
Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy.扩张型心肌病患者接受CorCap和二尖瓣环成形术后的神经激素及超声心动图结果
Ann Thorac Surg. 2009 Sep;88(3):719-25. doi: 10.1016/j.athoracsur.2009.05.050.
9
Relationship between the tissue Doppler-derived Tei index and plasma brain natriuretic peptide levels in patients with mitral regurgitation.二尖瓣反流患者组织多普勒衍生的Tei指数与血浆脑钠肽水平之间的关系。
J Heart Valve Dis. 2010 Jan;19(1):35-42.
10
Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.N末端B型脑钠肽前体在活动性感染性心内膜炎患者中的预后价值
Am J Cardiol. 2007 May 15;99(10):1429-33. doi: 10.1016/j.amjcard.2006.12.071. Epub 2007 Apr 5.

引用本文的文献

1
Left atrial size predicts outcome in severe but asymptomatic mitral regurgitation.左心房大小可预测严重但无症状性二尖瓣反流的结局。
Sci Rep. 2023 Mar 8;13(1):3892. doi: 10.1038/s41598-023-31163-0.
2
NT-proBNP increase during stress echocardiography predicts significant changes in ischemic mitral regurgitation severity in patients qualified for surgical revascularization.在有资格接受手术血运重建的患者中,应激超声心动图期间 NT-proBNP 的增加可预测缺血性二尖瓣反流严重程度的显著变化。
Cardiol J. 2022;29(6):927-935. doi: 10.5603/CJ.a2020.0078. Epub 2020 Jun 9.
3
Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation.
利钠肽在二尖瓣反流患者风险评估和预后中的功能作用
J Clin Med. 2020 May 5;9(5):1348. doi: 10.3390/jcm9051348.
4
Exercise capacity in asymptomatic patients with significant primary mitral regurgitation: independent effect of global longitudinal left ventricular strain.无症状重度原发性二尖瓣反流患者的运动能力:左心室整体纵向应变的独立影响
Cardiovasc Diagn Ther. 2018 Aug;8(4):460-468. doi: 10.21037/cdt.2018.05.03.
5
B-type Natriuretic Peptide as an Index of Symptoms and Severity of Chronic Rheumatic Mitral Regurgitation.B型利钠肽作为慢性风湿性二尖瓣反流症状和严重程度的指标。
Heart Views. 2016 Jan-Mar;17(1):7-12. doi: 10.4103/1995-705X.182648.
6
The role of B-type and other natriuretic peptides in health and disease.B型及其他利钠肽在健康与疾病中的作用。
Perm J. 2008 Fall;12(4):32-43. doi: 10.7812/TPP/08-019.
7
Comparison of N-terminal pro B-natriuretic Peptide and echocardiographic indices in patients with mitral regurgitation.二尖瓣反流患者N末端B型利钠肽原与超声心动图指标的比较。
Clin Med Insights Cardiol. 2010 Nov 30;4:111-6. doi: 10.4137/CMC.S6062.
8
Looking into the left atrial crystal ball: a ray of hope for patients with organic mitral regurgitation.窥视左心房的“水晶球”:为器质性二尖瓣反流患者带来一线希望。
J Am Coll Cardiol. 2010 Aug 10;56(7):579-81. doi: 10.1016/j.jacc.2009.11.103.
9
The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.氨基末端脑钠肽前体检测在临床心脏病学中的重要性。
Biomark Insights. 2007 Feb 7;1:143-55.
10
Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in patients with mitral regurgitation.二尖瓣反流患者心肌性能指数与血浆B型利钠肽水平的相关性
Int J Cardiovasc Imaging. 2008 Feb;24(2):151-7. doi: 10.1007/s10554-007-9237-5. Epub 2007 May 31.